Volume 51 Issue 1, January 2022

To overcome challenges such as the rift that has opened up between basic and clinical research, the scientific community first needs to understand the root of these issues. In a new article, Walker. et al. queried the opinion of US biomedical researchers on issues of reproducibility, rigor and attrition rates in drug development. While most researchers agree that there are problems in each of these areas, responses point to differences in researchers’ perspectives within the animal research community. Notably, researchers provide diverse explanations for the high attrition rates observed in drug development.

See Article, Walker

COVER IMAGE: Marina Spence. COVER DESIGN: Marina Spence.